Your browser doesn't support javascript.
loading
Molecular defects in coagulation Factor VIII and their impact on Factor VIII function.
Saenko, E L; Ananyeva, N; Kouiavskaia, D; Schwinn, H; Josic, D; Shima, M; Hauser, C A E; Pipe, S.
Afiliação
  • Saenko EL; J. Holland Laboratory, American Red Cross, 15601 Crabbs Branch Way, Rockville, MD 20855, USA. saenko@usa.redcross.org
Vox Sang ; 83(2): 89-96, 2002 Aug.
Article em En | MEDLINE | ID: mdl-12201837
ABSTRACT
Molecular defects in Factor VIII (FVIII), such as haemophilia A-related mutations or denaturative conformational changes, may affect the stability of FVIII as well as its interactions with physiological activators, von Willebrand Factor, phospholipid, or conformationally sensitive antibodies. We summarize the contemporary assays which allow identification of impaired functional interactions of FVIII that cause a reduction or loss of its cofactor activity and/or increased immunogenicity. These assays can potentially be used for detection of molecular defects in FVIII and elucidation of the function impaired by these defects.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Fator VIII Idioma: En Ano de publicação: 2002 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Fator VIII Idioma: En Ano de publicação: 2002 Tipo de documento: Article